DONATE

IBEC, one of the centres selected by the Pasqual Maragall Foundation for its research grants

Amaya Hernández-Vega, a senior researcher at IBEC, will lead one of the two projects selected in the 2024 call for proposals from the Pasqual Maragall Research Programme, which is dedicated to funding research into Alzheimer’s disease and other neurodegenerative conditions. IBEC also celebrates the participation of Jordi Duran, an associate researcher from the Molecular and Cellular Neurobiotechnology group, who will collaborate on the second selected project.

Scientists reverse Alzheimer’s in mice using nanoparticles

An international team co-led by the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital Sichuan University (WCHSU) was able to reverse Alzheimer’s in mice after only 3 injections with nanoparticles. The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now. This achievement, published in the Signal Transduction and Targeted Therapy Journal, is a promising step towards an effective treatment for Alzheimer’s disease.

IBEC and IQS host the 2nd Barcelona Blood-Brain Barrier Conference

The event, jointly organised by the Institute for Bioengineering of Catalonia (IBEC) and the Institut Químic de Sarrià (IQS), brought together leading scientists from around the world to discuss the latest advances in blood-brain barrier (BBB) research, from its fundamental biology to its role in disease and therapeutic strategies.

IBEC to lead two biomedical projects under the CaixaImpulse programme

Anna Lagunas and Daniel González-Carter, who are both senior researchers at the Institute of Bioengineering of Catalonia (IBEC), will be leading these projects as part of the 2025 edition of the programme. This initiative by the “la Caixa” Foundation aims to accelerate the commercialisation of biomedical innovations to make them available to patients who need them more quickly. The two IBEC projects focus on treating diseases that affect the brain.

IBEC and UNIST Host Forum on Next-generation Bioengineering to Strengthen International Collaboration

Today took place the Forum on Next-generation Bioengineering organized by the Institute for Bioengineering of Catalonia (IBEC) and Ulsan National Institute of Science & Technology (UNIST) in South Korea. The event highlighted cutting-edge research in bioengineering and reinforced the collaborative ties between the two institutions.

Scientists create an artificial cell capable of navigating its environment using chemistry alone

Researchers at the Institute for Bioengineering of Catalonia (IBEC) have created the world’s simplest artificial cell capable of chemical navigation, migrating toward specific substances like living cells do. This breakthrough, published in Science Advances, demonstrates how microscopic bubbles, called vesicles, can be programmed to follow chemical trails. This breakthrough reveals the bare essentials needed to make synthetic life move with purpose. Decoding how vesicles navigate reveals how cells communicate and transport cargo, and provides a blueprint for engineering targeted drug delivery systems

IBEC co-funds new state-of-the-art electron microscope

The President of the Catalan Government, Salvador Illa, and the Catalan Minister for Research and Universities, Núria Montserrat, inaugurated this unique infrastructure at the Barcelona Science Park today. The microscope, funded by IBEC and FEDER*, opens the door to the reconstruction of biomolecules and viruses in three dimensions, among other applications.

IBEC and SJD Barcelona Children’s Hospital strengthen their collaboration with a day of translational innovation

The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.

Advances in nanobiotechnology and nanomedicine explored at the 12th International NanoBio&Med Conference

The latest developments in nanotechnology, biotechnology and medicine were presented at the NanoBio&Med 2024 International Conference, held this week at the Barcelona Science Park (PCB) from 5 to 7 November. This is an annual event designed to establish new collaborations and promote innovative projects in the scientific-industrial sector.